Skip to content

Nalu Medical, Inc. 71007-US (UDI 00812537035512)Recalls & reported problems

Nalu Medical, Inc. · Nalu Neurostimulation Kit (Ported, Single 4) · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00812537035512), received between Jun 20, 2024 and Jun 20, 2024 — classified as 1 injury.

The most frequently reported specific device problem is “Intermittent Communication Failure” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 1 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Intermittent Communication Failure1

Patient problems

  • Inadequate Pain Relief1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryJun 20, 2024Intermittent Communication Failure; Intermittent Communication Failure

    PATIENT WAS IMPLANTED WITH A NALU PERIPHERAL NERVE STIMULATOR SYSTEM ON (B)(6) 2021 TO TREAT LOWER LEG AND FOOT PAIN. IN (B)(6) 2024 THE PATIENT REPORTED SOME ISSUES WITH COMMUNICATION BETWEEN THE IMPLANTABLE PULSE GENERATOR (IPG) AND THE EXTERNAL THERAPY DISCS. TROUBLESHOOTING WAS PERFORMED AND UNABLE TO DETERMINE THE CAUSE OF THE ISSUES. ON (B)(6) 2024 A SURGICAL REVISION WAS PERFORMED TO REPLACE THE IPG. THE IMPLANTED LEADS REMAINED IN PLACE AND WERE CONNECTED TO THE NEW IPG. THE EXPLANTED IPG WAS RETAINED BY THE MEDICAL FACILITY AND IS NOT AVAILABLE TO THE FIRM FOR FURTHER INVESTIGATION.

    Patient problems: Inadequate Pain Relief

    MAUDE report 19572316 ↗

Other Stimulator, Peripheral Nerve, Implanted (Pain Relief) devices

All Stimulator, Peripheral Nerve, Implanted (Pain Relief) devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page